CDK4 and cancer: Cancer cells frequently bypass the RB-dependent restriction point in the G1 phase of the cell cycle, typically through alterations in cell cycle machinery genes that lead to constitutive Cyclin D–CDK4/6 activation, or through the loss of RB itself [70].